Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer.

Theodora A ConstantinAnabel Varela-CarverKyle K GreenlandGilberto Serrano de AlmeidaEllen OldenLucy PenfoldSimon AngAlice OrmrodDamien A LeachChun-Fui LaiEdward K AinscowAsh K BahlDavid CarlingMatthew John Fuchter Simak Ali Charlotte Lynne Bevan

Published in: British journal of cancer (2024)

Keyphrases

prostate cancer
radical prostatectomy
image quality
dual energy
cell cycle
computed tomography
signaling pathway
contrast enhanced
positron emission tomography
magnetic resonance imaging
cell proliferation